GENOMIGON Trademark

Genetic testing apparatus for medical purposes; diagnostic equipment and instruments for medical purposes for the analysis of body fluids, benign and malignant tissue and blood, protein structures of tumors, genetic code of tissue and blood cells, analysis of blood cells, blood plasma and blood serum; medical apparatus for carrying-out diagnostic tests for medical purposes for cancer cells, leukemia cells, benign and malignant cells of humans and animals, genetic material; medical testing instruments for medical diagnostic purposes for blood sugar levels, cancer cells, genetic material; electromedical diagnostic instruments, namely, electromedical rehabilitative and pain management products for clinical and home use, namely, electrical nerve and muscle stimulators, ultrasonic stimulators, magnet therapy stimulators and laser therapy stimulators; radiation instruments, for medical purposes, namely, radiation therapy devices; medical radiation apparatus for medical purposes; medical apparatus for the treatment of cancer; apparatus for DNA and RNA testing for medical purposes; all the aforesaid goods relating to the fields of oncology, chemotherapy, molecular genetics, molecular medicine

Pharmaceutical preparations and substances for the treatment of malignant tumor diseases and malignant and benign blood diseases, and infectious diseases; diagnostic preparations and materials for medical purposes; diagnostic substances for medical use; diagnostic testing materials for medical use, namely, medical diagnostic test media in the form of, strips, threads, liquids, gels, and serums, for measuring, biomarkers in malignant diseases and hereditary diseases on a genetic basis or protein basis, gene variants in hereditary diseases and malignant diseases; medical diagnostic test strips for blood analysis, urine analysis, and saliva analysis; biotechnological preparations for medical use in the nature of pharmaceutical preparations for the treatment of cancer, malignant and non-malignant blood diseases and hereditary diseases; medicine, namely, cytostatics for medical purposes, antibodies for medical purposes, antibody-drug conjugates, therapeutically modified lymphocytes, mixed hormone preparations, preparations for the targeted treatment of malignant and non-malignant diseases in the nature of targeted delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals that inhibit, activate or modulate regulatory cascades in malignant and non-malignant diseases or the microenvironment such as tyrosine kinase inhibitors, antibodies, antibody drug conjugates, immune checkpoint inhibitors, T cell engagers, modified effector cell preparations such as CAR-T cells, bispecific or multispecific antibodies, antibody-nuclide conjugates; biopharmaceuticals for medical purposes in the nature of pharmaceutical preparations for the treatment of, malignant blood diseases, benign blood diseases, malignant solid tumors, benign solid tumors, cancer and hereditary diseases; biopharmaceuticals for medical purposes in the nature of pharmaceutical preparations for healing or alleviating ailments and reducing symptoms of blood diseases; biological preparations for medical purposes, namely, biological preparations for the treatment of, malignant blood diseases, benign blood diseases, malignant solid tumors, and benign solid tumors; all the aforesaid goods relating to the fields of oncology, chemotherapy, molecular genetics, molecular medicine

Medical services; medical analysis services relating to disease management, disease diagnosis services, disease prognosis; medical laboratory services for the analysis of samples taken from patients; health screening services in the field of malignant tumor diseases, benign tumor diseases, malignant blood diseases, benign blood diseases, hereditary diseases, coagulation disorders; providing medical information in the healthcare sector; medical consultations; arranging of medical treatment in the field of oncology, hematology, genetics, gene therapies, targeted therapy, cell therapies; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; all the aforesaid services relating to the fields of oncology, chemotherapy, molecular genetics, molecular medicine

Scientific analysis in the field of pharmaceuticals, and medical devices; scientific research in the field of genetics, hematology, and oncology; genetic scientific research; pharmaceutical research services; clinical research in the field of radiology, radiotherapy, surgical medicine, oncological system therapy of malignant and benign diseases, and infectious diseases; research relating to biotechnology; medical research; computer aided diagnostic testing services, namely, diagnostic services for others for scientific research purposes; design and development of medical diagnostic apparatus; design and development of medical technology; development of pharmaceutical preparations and medicines; provision of information and data relating to medical and veterinary research and development; consultancy relating to research and development in the field of therapeutics; providing scientific research information in the field of medical disorders and their treatment; laboratory testing and analysis for medical research purposes in the field of bacteriology, chemistry, life science, molecular genetics, protein diagnostics, oncology, hematology, radiology, and radiotherapy; biomedical assay services and development for the analysis of body fluids, tissue samples and fluids and blood and blood products for benign and malignant diseases in the field of diagnostic preparations, implements and medication; all the aforesaid services relating to the fields of oncology, chemotherapy, molecular genetics, molecular medicine